Ardelyx | ARDX - Selling And Administration Expenses

Stock Price
6.23
Daily Change
-0.23 -3.56%
Monthly
-0.80%
Yearly
60.57%
Q2 Forecast
6.64

Ardelyx reported $75.92M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Abbott USD 3.27B 138M Mar/2026
Amgen USD 1.58B 354M Mar/2026
Ardelyx USD 75.92M 7.69M Dec/2025
aTyr Pharma USD 82.26M 77.46M Dec/2025
Corcept Therapeutics USD 128.04M 13.3M Mar/2026
Curis USD 1.34M 3.45M Dec/2025
Sanofi EUR 2.75B 455M Dec/2025
TG Therapeutics USD 73.14M 22.42M Mar/2026
United Therapeutics USD 156.6M 34M Mar/2026
Xoma USD 11M 2.54M Jun/2024